Novel 18-gene urine test improves detection of clinically significant #ProstateCancer . Jeff Tosoian, MD, MPH Vanderbilt Urology joins Andrea Miyahira Prostate Cancer Foundation to discuss this new tool in #PCa diagnosis and research published in JAMA Oncology > bit.ly/3U6pih0 U-M Rogel Cancer Center Vanderbilt-Ingram Cancer Center

For those that prefer watching to reading (i.e. everyone). Thanks for having me on! UroToday.com Andrea Miyahira

Join Andrea Miyahira Prostate Cancer Foundation in a conversation with Louise Emmett sharing her unconventional journey into #NuclearMedicine and theranostics. From challenging norms to breaking gender barriers. #WatchNow on UroToday > bit.ly/48mDTue ANZUP

The Prostate Cancer Foundation #WomenInScience Forum: Empowering female researchers through networking and mentorship. Veda Giri, Ayesha Shafi, PhD, & Claire E Fletcher join Andrea Miyahira in this discussion on UroToday > bit.ly/48oKt3l

Decoding the complex interplay of hormone therapy and lineage plasticity in #ProstateCancer . Amina Zoubeidi Vancouver Prostate Centre joins Andrea Miyahira Prostate Cancer Foundation delving into her recent work in this conversation on UroToday > bit.ly/46yoUw1

#WatchNow Tanya Stoyanova Stoyanova Lab at UCLA and Andrea Miyahira delve into #Trop2 's role, revealing its potential as a therapeutic target & urinary biomarker. This collaborative study highlights the promise of non-invasive disease monitoring > bit.ly/43rbceo Scientific Reports

“More than any other platform, [TikTok] has this unmatched potential to amplify the reach and growth of science communication content.” scim.ag/6hl

Targeting myeloid chemotaxis to reverse #ProstateCancer therapy resistance. Andrea Miyahira Prostate Cancer Foundation is joined by Prof Johann De Bono The ICR to discuss his group's paper published in nature > bit.ly/3SPdHlV The Royal Marsden NHS Foundation Trust

Research reveals how metabolic rewiring enables 'Persister' cancer cells to resist death and treatment. Asmaa El-Kenawi (She/her) Indiana University joins Andrea Miyahira Prostate Cancer Foundation to discuss her group's research on therapeutic resistance in cancer > bit.ly/4aRhgjH

#ProstateCancer cell metabolism dictates differentiation and therapy response. Andrew Goldstein joins Andrea Miyahira to discuss his group's findings published in Nature Cell Biology and how metabolic processes shape prostate cancer's response to treatment > bit.ly/49cwb6F

Study reveals African ancestry gene variant is strongly linked to highly aggressive forms of #ProstateCancer . Mayuko Kanayama, MD, PhD The Johns Hopkins Brady Urological Institute joins Andrea Miyahira Prostate Cancer Foundation to discuss her team's research on a HOXB13 variant in this discussion > bit.ly/41SELF0

Prostate SPORE Retreat 2024 ⁦Felix Feng⁩ ⁦Amina Zoubeidi⁩ ⁦Josh Lang⁩ ⁦PCF Science⁩

Advancing health equity: American Cancer Society's strategic approach. Join Tawana Thomas Johnson and Andrea Miyahira to learn about the importance of continuous learning, community engagement, and the ACS's initiatives tackling #ProstateCancer disparities > bit.ly/47jUr56 Prostate Cancer Foundation

PCF has funded dozens of women who have dedicated their careers to solving the most complex problems in prostate cancer.

Our Global Director of Scientific Communications, Andrea Miyahira discusses this important topic w/ Alicia Morgans, MD, MPH on UroToday.com

tinyurl.com/4ycv6snz

Wondering whether GG2 are of unclear significance--what is the endpoint of interest in #ProstateCancer detection trials in MRI era? Please vote below👇and share thoughts. Thank you!
Hashim U. Ahmed Caroline Moore Michael Leapman Stacy Loeb, MD Benjamin J. Davies MD Matt Cooperberg Todd 〽️ Morgan, MD
Dave Penson

Join Andrea Miyahira Prostate Cancer Foundation in a conversation with Louise Emmett sharing her unconventional journey into #NuclearMedicine and theranostics. From challenging norms to breaking gender barriers. #WatchNow on UroToday > bit.ly/48mDTue ANZUP

The Prostate Cancer Foundation #WomenInScience Forum: Empowering female researchers through networking and mentorship. Veda Giri, Ayesha Shafi, PhD, & Claire E Fletcher join Andrea Miyahira in this discussion on UroToday > bit.ly/48oKt3l

Thank you 🙏 UroToday.com Andrea Miyahira of PCF Science for discussing and highlighting our recent work published in Cancer Cell !!
cell.com/cancer-cell/pd…

Targeting myeloid chemotaxis to reverse #ProstateCancer therapy resistance. Andrea Miyahira Prostate Cancer Foundation is joined by Prof Johann De Bono The ICR to discuss his group's paper published in nature > bit.ly/3SPdHlV The Royal Marsden NHS Foundation Trust

Join us for the PCF DNA repair working group's panel discussion on 'Emerging Trends in PARP Targeting Therapies'. Feel free to send us your questions that you want us to discuss ([email protected]). #pcf #prostatecancer #parpi PCF Science